Y Du, R Wang - Journal of chemical theory and …, 2020 - pubmed.ncbi.nlm.nih.gov
Protein kinase inhibitors disrupt phosphorylation of the target kinases, which are an
important class of drug for treating cancer and other diseases. Conventional structure-based …